Marriott CEO Sorenson to Reduce Work Schedule to Undergo Further Cancer Treatment – Skift

Marriott Tuesday outlined a temporary shift in its leadership structure while its chief executive, Arne Sorenson, seeks further treatment for his pancreatic cancer.

Sorenson will remain president and CEO of the company while he undergoes more aggressive treatment. He was first diagnosed with pancreatic cancer in 2019.

“Since my diagnosis, I’ve been working with a great medical team at Johns Hopkins to treat this cancer,” Sorenson said in a statement. “While I have worked throughout my treatment to date and plan to remain as engaged in the business as my health allows, the right thing to do for me, my family and the company is to focus on my health.”

Leadership responsibilities will be split between Stephanie Linnartz — Marriott’s group president of consumer operations, technology, and emerging businesses — and Tony Capuano — the company’s group president of global development, design, and operations services.

“I know Stephanie and Tony will work with Marriott’s strong executive team to continue to move the company forward,” Sorenson said. “I, along with my family and my medical team, remain optimistic about my prognosis and I plan to return full-time after the conclusion of my treatments.”

Marriott declined to comment further when contacted by Skift.

This is a developing story.

See full article